You are here

Lifitegrast

Shire Secures Access to 16 Million-Strong US Dry Eye Disease Market With New Drug Approval

Forbes

Tue, 07/12/16 - 11:04 am

dry eye disease

Allergan execs see Restasis withstanding rivalry with prospective Shire med

Fierce Pharma Marketing

Wed, 02/24/16 - 10:50 am

dry eye disease

Shire's self-described blockbuster eye drug lines up for FDA do-over

Fierce Biotech

Sat, 02/6/16 - 12:18 pm

dry eye disease

Shire's back on track with its dry-eye threat to Allergan's Restasis

Fierce Pharma Marketing

Wed, 01/27/16 - 10:25 am

dry eye disease

Shire gets back on track with once-rejected eye drug

Fierce Biotech

Mon, 01/25/16 - 10:51 am

dry eye disease

Auven Therapeutics pits rival PhIII dry eye drug against Allergan, Shire

Fierce Biotech

Fri, 11/13/15 - 11:01 am

Auven Therapeutics

dry eye disease

Shire says its once-rejected eye drug is back on track with a Phase III success

Fierce Biotech

Tue, 10/27/15 - 09:42 am

dry eye disease

Shire Aims to Refile Blockbuster Eye Drug in First Quarter

Bloomberg

Mon, 10/19/15 - 09:59 am

dry eye disease

FDA eye drug rebuff adds to Shire's woes in Baxalta pursuit

Yahoo/Reuters

Sat, 10/17/15 - 03:10 pm

3 Big Drugs Likely To Hit The Market Soon

Investors.com

Wed, 09/30/15 - 04:56 pm

Gilead Sciences

Shire nabs priority review for potential blockbuster dry eye drug

BioPharma Dive

Fri, 04/10/15 - 10:48 am

dry eye disease

Shire to submit dry eye treatment to U.S. drug regulator

Yahoo/Reuters

Fri, 05/16/14 - 03:45 pm

dry eye disease

Shire says new dry-eye drug fails to meet trial goal

Yahoo/Reuters

Wed, 04/30/14 - 10:23 am

dry eye disease

Shire's new dry eye drug disappoints in pivotal trial

Yahoo/Reuters

Fri, 12/6/13 - 09:04 am

dry eye disease